Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Jy Kang

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|June 23, 2025
Donanemab: The dawn of disease-modifying treatment for Alzheimer's disease in AustraliaSamantha M Loi, Matthew Jy Kang
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersMatthew Jy Kang, Dhamidhu Eratne, Christa Dang, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|June 19, 2026
Vascular risk factors in maintenance versus acute electroconvulsive therapy: A retrospective case-control study from a regional Australian serviceFesochi Atulayo, Matthew Jy Kang, Kim S Carey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersDhamidhu Eratne, Jeff Smith, Kruti Patel, et al.
Acta Neuropsychiatrica|April 17, 2026
Improved dietary control results in improvements in indices of white matter structure in adults with phenylketonuria: the ReDAPT studyMatthew Jy Kang, Christopher Adamson, Charles B Malpas, et al.
Brain, Behavior, and Immunity|November 7, 2024
Neurofilament light and glial fibrillary acidic protein in mood and anxiety disorders: A systematic review and meta-analysisMatthew Jy Kang, Jasleen Grewal, Dhamidhu Eratne, et al.
The Australian and New Zealand Journal of Psychiatry|January 18, 2025
Blood biomarker profiles in young-onset neurocognitive disorders: A cohort studyOneil G Bhalala, Jessica Beamish, Dhamidhu Eratne, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|June 23, 2025
Donanemab: The dawn of disease-modifying treatment for Alzheimer's disease in AustraliaSamantha M Loi, Matthew Jy Kang
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersMatthew Jy Kang, Dhamidhu Eratne, Christa Dang, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|June 19, 2026
Vascular risk factors in maintenance versus acute electroconvulsive therapy: A retrospective case-control study from a regional Australian serviceFesochi Atulayo, Matthew Jy Kang, Kim S Carey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersDhamidhu Eratne, Jeff Smith, Kruti Patel, et al.
Acta Neuropsychiatrica|April 17, 2026
Improved dietary control results in improvements in indices of white matter structure in adults with phenylketonuria: the ReDAPT studyMatthew Jy Kang, Christopher Adamson, Charles B Malpas, et al.
Brain, Behavior, and Immunity|November 7, 2024
Neurofilament light and glial fibrillary acidic protein in mood and anxiety disorders: A systematic review and meta-analysisMatthew Jy Kang, Jasleen Grewal, Dhamidhu Eratne, et al.
The Australian and New Zealand Journal of Psychiatry|January 18, 2025
Blood biomarker profiles in young-onset neurocognitive disorders: A cohort studyOneil G Bhalala, Jessica Beamish, Dhamidhu Eratne, et al.
Pageof 1